Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.

× No keyword cloud information.

14 in total

1. Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002).

Authors: Alessandro D Santin; Wei Deng; Michael Frumovitz; Natalia Buza; Stefania Bellone; Warner Huh; Samir Khleif; Heather A Lankes; Elena S Ratner; Roisin E O'Cearbhaill; Amir A Jazaeri; Michael Birrer
Journal: Gynecol Oncol Date: 2020-01-07 Impact factor: 5.482

Review 2. Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine.

Authors: Dmitriy Zamarin; Amir A Jazaeri
Journal: Gynecol Oncol Date: 2016-04 Impact factor: 5.482

Review 3. [Prophylactic and therapeutic vaccines against human papilloma virus].

Authors: A E Albers; T K Hoffmann; J P Klussmann; A M Kaufmann
Journal: HNO Date: 2010-08 Impact factor: 1.284

4. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.

Authors: Dodie S Pouniotis; Owen Proudfoot; Violeta Bogdanoska; Vasso Apostolopoulos; Theodora Fifis; Magdalena Plebanski
Journal: Infect Immun Date: 2004-09 Impact factor: 3.441

Review 5. Progress on new vaccine strategies against chronic viral infections.

Authors: Jay A Berzofsky; Jeffrey D Ahlers; John Janik; John Morris; SangKon Oh; Masaki Terabe; Igor M Belyakov
Journal: J Clin Invest Date: 2004-08 Impact factor: 14.808

Review 6. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.

Authors: Chien-Fu Hung; Barbara Ma; Archana Monie; Shaw-Wei Tsen; T-C Wu
Journal: Expert Opin Biol Ther Date: 2008-04 Impact factor: 4.388

7. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.

Authors: Stefania Bellone; Karim El-Sahwi; Emiliano Cocco; Francesca Casagrande; Marilisa Cargnelutti; Michela Palmieri; Eliana Bignotti; Chiara Romani; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Journal: J Virol Date: 2009-04-22 Impact factor: 5.103

8. Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients.

Authors: Alfonso Ferrara; Marion Nonn; Peter Sehr; Carola Schreckenberger; Michael Pawlita; Matthias Dürst; Achim Schneider; Andreas M Kaufmann
Journal: J Cancer Res Clin Oncol Date: 2003-07-30 Impact factor: 4.553

Review 9. Antigen-specific immunotherapy of cervical and ovarian cancer.

Authors: Chien-Fu Hung; T C Wu; Archana Monie; Richard Roden
Journal: Immunol Rev Date: 2008-04 Impact factor: 12.988

10. Therapeutic vaccines against human papillomavirus and cervical cancer.

Authors: Angel Cid-Arregui
Journal: Open Virol J Date: 2009-10-23